Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s):  BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.


CSE:BIOV - Post by User

Post by moneynorthboundon Nov 11, 2020 3:28pm
199 Views
Post# 31878985

BIOV MACKIE & CANNACORD STILL BUYING @36. CHARTS TELL TRUTH

BIOV MACKIE & CANNACORD STILL BUYING @36. CHARTS TELL TRUTH

Recent Trades

 newer reset older 
Seller Buyer Price Volume Total Time
Anonymous CIBC 0.360 10,000 $3,600 15:07
Anonymous Latimer 0.360 1,000 $360 14:57
Latimer TD Sec 0.360 111 $39 14:57
Anonymous TD Sec 0.360 500 $180 14:57
Anonymous Mackie 0.360 10,000 $3,600 14:57
Anonymous Mackie 0.360 20,000 $7,200 14:56
Questrade Mackie 0.360 15,000 $5,400 14:56
Questrade Scotia 0.360 5,000 $1,800 14:56
Anonymous Scotia 0.360 5,000 $1,800 14:56
Anonymous RBC 0.350 15,500 $5,425 14:55
Anonymous Canaccord 0.355 1,500 $532 14:55
TD Sec RBC 0.350 5,000 $1,750 14:55
Anonymous Latimer 0.350 3,000 $1,050 14:54
Anonymous Anonymous 0.350 20,000 $7,000 14:54
Anonymous Latimer 0.350 2,000 $700 14:54
RBC Canaccord 0.345 1,500 $517 14:53
National Bank Canaccord 0.345 1,000 $345 14:53
Questrade Canaccord 0.345 500 $172 14:53
Questrade Anonymous 0.345 2,500 $862 14:53
Canaccord Canaccord 0.340 15,000 $5,100 14:51
Anonymous TD Sec 0.340 16,500 $5,610 14:34
Anonymous TD Sec 0.335 13,000 $4,355 14:34
CIBC Latimer 0.335 1,500 $502 14:28
CIBC Anonymous 0.335 4,000 $1,340 14:26
CIBC Latimer 0.335 2,000 $670 14:19
CIBC BMO Nesbitt 0.335 500 $167 14:19
Anonymous Questrade 0.340 3,500 $1,190 14:16

<< Previous
Bullboard Posts
Next >>